Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms SNIPER(TACC3)-11 |
Target |
Mechanism FGFR3 antagonists(Fibroblast growth factor receptor 3 antagonists), TACC3 inhibitors(Transforming acidic coiled protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC51H66N10O7S2 |
InChIKeyCTMIQTSKAZXRFZ-YSQZVTEJSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 24 Jan 2022 |